Memphasys secures UK market entry, accelerating commercial rollout
Memphasys has entered the U.K. fertility market with four IVF groups putting in commercial orders to trial its Felix system.
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| CD3 | Ann: Net Tangible Asset Backing & Fund Update | 13/04/18 | 0 | 41 | |||
|
|||||||
| CD3 | Ann: Net Tangible Asset Backing & Fund Update | 14/03/18 | 0 | 57 | |||
|
|||||||
See All Discussions
ASX News